However, the data on Nrf2’s role in the pathogenesis of atherosclerosis and modulation of CD36 expression and foam cell formation remain controversial, and our data presented here clearly demonstrate that SFN, a potent Nrf2 activator, does not promote macrophages’ expression of CD36 and internalization of cholesterol. The gene discussed is CD36; the disease is atherosclerosis.